As we conclude our years-long exploration of pricing in healthcare, the central theme of our 2023 Business of Health Conference, we are pleased to present our final output on the topic: a whitepaper that delves into pharmaceutical pricing and innovation. Produced following a Chatham House Rules conference earlier this year, the whitepaper aims to provide general audiences with insights into the complexities of pharmaceutical innovation and pricing, as well as the current realities within our healthcare system related to this critical issue.